Annual CFI
N/A
December 31, 2022
Summary
- BLPH annual cash flow from investing activities is not available.
Performance
BLPH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$140.00 K
NaN%
September 30, 2023
Summary
- As of February 26, 2025, BLPH quarterly cash flow from investing activities is $140.00 thousand
- Over the past year, BLPH quarterly CFI has increased by +$140.00 thousand (+100.00%).
Performance
BLPH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$140.00 K
NaN%
September 30, 2023
Summary
- As of February 26, 2025, BLPH TTM cash flow from investing activities is $140.00 thousand
- Over the past year, BLPH TTM CFI has increased by +$140.00 thousand (+100.00%).
Performance
BLPH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BLPH Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +100.0% |
| 3 y3 years | - | +100.0% | +100.0% |
| 5 y5 years | - | -90.7% | +100.0% |
BLPH Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% | ||
| 5 y | 5-year | at high | -100.0% | at high | -100.0% | ||
| alltime | all time | -97.0% | -9852.9% | -98.9% | <-9999.0% |
Bellerophon Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $140.00 K(>+9900.0%) | $140.00 K(>+9900.0%) |
| Sep 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2018 | $3.00 M(+16.4%) | $999.00 K(-33.4%) | $3.00 M(+37.3%) |
| Sep 2018 | - | $1.50 M(+198.6%) | $2.19 M(+55.1%) |
| Jun 2018 | - | $502.00 K(+172.8%) | $1.41 M(-45.3%) |
| Dec 2017 | $2.58 M(-78.9%) | $184.00 K(-74.6%) | $2.58 M(-36.3%) |
| Sep 2017 | - | $723.00 K(-191.8%) | $4.05 M(-49.4%) |
| Jun 2017 | - | -$788.00 K(-132.1%) | $8.01 M(-38.2%) |
| Mar 2017 | - | $2.46 M(+48.5%) | $12.95 M(+6.2%) |
| Dec 2016 | $12.20 M | $1.66 M(-64.6%) | $12.20 M(+21.3%) |
| Sep 2016 | - | $4.68 M(+12.5%) | $10.06 M(-221.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $4.16 M(+144.3%) | -$8.28 M(-50.1%) |
| Mar 2016 | - | $1.70 M(-450.4%) | -$16.60 M(-9.3%) |
| Dec 2015 | -$18.30 M(<-9900.0%) | -$486.00 K(-96.4%) | -$18.30 M(+2.7%) |
| Sep 2015 | - | -$13.65 M(+227.8%) | -$17.82 M(+327.8%) |
| Jun 2015 | - | -$4.17 M(<-9900.0%) | -$4.17 M(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | -$727.00 K(-79.1%) | - | - |
| Dec 2012 | -$3.48 M | - | - |
FAQ
- What is the all time high annual CFI for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly CFI year-on-year change?
- What is Bellerophon Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics TTM CFI year-on-year change?
What is the all time high annual CFI for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual cash flow from investing activities is $12.20 M
What is Bellerophon Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BLPH is $140.00 K
What is the all time high quarterly CFI for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly cash flow from investing activities is $4.68 M
What is Bellerophon Therapeutics quarterly CFI year-on-year change?
Over the past year, BLPH quarterly cash flow from investing activities has changed by +$140.00 K (+100.00%)
What is Bellerophon Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BLPH is $140.00 K
What is the all time high TTM CFI for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high TTM cash flow from investing activities is $12.95 M
What is Bellerophon Therapeutics TTM CFI year-on-year change?
Over the past year, BLPH TTM cash flow from investing activities has changed by +$140.00 K (+100.00%)